Kristen Ambrose, SVP & Chief Accounting Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 465 shares at $419.00 ($195K) on 2024-04-02, disclosed to the SEC on 2024-04-03.
Scheduled sale ($195k) by SVP & Chief Accounting Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $418.10 | 225 | $94K | 48.3% |
| 2 | $419.00 | 240 | $101K | 51.7% |
| Total | $418.56 avg | 465 | $195K | 100% |
| Filing → |
| VRTX | SELL | 2026-02-19 | $1.1M | — | Filing → |
| VRTX | SELL | 2026-02-12 | $634K | — | Filing → |
| VRTX | SELL | 2025-02-26 | $850K | — | Filing → |